Alligator Bioscience AB (7AL0) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Alg.Apv-527 | Solid Tumor | phase1AndPhase2 | Recruiting | ALG.APV-527 First-in-human Study | Feb 26, 2023 | ― |
| Cd40 Agonist Mitazalimab In Combination With Chemotherapy | Metastatic Pancreatic Ductal Adenocarcinoma | phase1AndPhase2 | Active Not Recruiting | Safety and Efficacy of Mitazalimab in Combination with Chemotherapy in Pancreatic Cancer Patients | May 06, 2021 | ― |
| Ator-1017 | Solid Tumor, Neoplasms | Phase I | Completed | Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017 | Oct 08, 2019 | ― |
| Ator-1015 | Solid Tumor, Neoplasms | Phase I | Completed | Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015 | Dec 14, 2018 | ― |
| Adc-1013 | Neoplasms, Solid Tumors | Phase I | Completed | ADC-1013 First-in-Human Study | Feb 16, 2015 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Alg.Apv-527 | phase1AndPhase2 | Solid Tumor | Recruiting | ALG.APV-527 First-in-human Study | Feb 26, 2023 | ― |
| Cd40 Agonist Mitazalimab In Combination With Chemotherapy | phase1AndPhase2 | Metastatic Pancreatic Ductal Adenocarcinoma | Active Not Recruiting | Safety and Efficacy of Mitazalimab in Combination with Chemotherapy in Pancreatic Cancer Patients | May 06, 2021 | ― |
| Ator-1017 | Phase I | Solid Tumor, Neoplasms | Completed | Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017 | Oct 08, 2019 | ― |
| Ator-1015 | Phase I | Solid Tumor, Neoplasms | Completed | Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015 | Dec 14, 2018 | ― |
| Adc-1013 | Phase I | Neoplasms, Solid Tumors | Completed | ADC-1013 First-in-Human Study | Feb 16, 2015 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Alligator Bioscience AB (DE:7AL0) have in its pipeline
Alligator Bioscience AB DE:7AL0 is currently developing the following drugs: Alg.Apv-527, Cd40 Agonist Mitazalimab In Combination With Chemotherapy, Ator-1017, Ator-1015, Adc-1013. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
